tiprankstipranks
Scinai Immunotherapeutics (SCNI)
NASDAQ:SCNI

Scinai Immunotherapeutics (SCNI) Financial Statements

283 Followers

Scinai Immunotherapeutics Financial Overview

Scinai Immunotherapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Scinai Immunotherapeutics is scheduled to report earnings on May 30, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--₪ 0.00₪ 0.00₪ 0.00
Gross Profit-----
EBIT₪ 3.52M-₪ 9.91M₪ -9.21M₪ -7.07M
EBITDA₪ 3.65M-₪ 9.91M₪ -8.43M₪ -7.07M
Net Income Common Stockholders₪ 3.52M-₪ 3.75M₪ -12.85M₪ -9.42M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments₪ 10.93M₪ 14.21M₪ 29.44M₪ 39.50M₪ 48.89M
Total Assets₪ 23.29M₪ 27.07M₪ 74.72M₪ 85.57M₪ 95.54M
Total Debt₪ 23.28M₪ 21.54M₪ 62.02M₪ 77.05M₪ 71.57M
Net Debt₪ 12.35M₪ 7.33M₪ 32.58M₪ 37.55M₪ 22.69M
Total Liabilities₪ 28.10M₪ 28.83M₪ 65.36M₪ 81.10M₪ 79.37M
Stockholders Equity₪ -4.81M₪ -1.76M₪ 9.36M₪ 4.47M₪ 16.17M
Cash Flow-
Free Cash Flow₪ -3.07M--₪ -10.45M-
Operating Cash Flow₪ -3.07M--₪ -10.41M-
Investing Cash Flow₪ -6.00K--₪ -84.00K-
Financing Cash Flow---₪ -468.00K-
Currency in ILS

Scinai Immunotherapeutics Earnings and Revenue History

Scinai Immunotherapeutics Debt to Assets

Scinai Immunotherapeutics Cash Flow

Scinai Immunotherapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis